JPMorgan raised the firm’s price target on Equitable Holdings to $45 from $36 and keeps a Neutral rating on the shares as part of a Q2 life insurance preview. The long-term fundamental outlook for the life insurance business is “downbeat, but we feel that the risk-reward in stocks is compelling,” the analyst tells investors in a research note. The firm cites a favorable macro backdrop, healthy balance sheets and ongoing share repurchases, and cautious investor sentiment for its favorable stance on the stocks. Valuation multiples have recovered off mid-2023 lows, but remain attractive, says JPMorgan.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EQH:
- Equitable Holdings price target raised to $51 from $46 at Jefferies
- Equitable Holdings Issues Securities and Projects Earnings Impact
- Equitable Holdings cut to Neutral at UBS on likely peak in net interest income
- Equitable Holdings downgraded to Neutral from Buy at UBS
- Equitable Holdings participates in a conference call with JPMorgan